|
|
| Maladies Cardiovasculaires > Etude de marché sectorielle |
| Laboratory Assessment of Diabetic Vascular Disease |
|
|
|
|
€ 80,00 |
Editeur
: |
TriMark |
Langue
: |
Anglais |
Date de publication : |
Janvier 2006 |
Taille du document : |
1 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Commercial Insight: Cancer Market Top 20 Drugs - Supportive Care Grows the Cancer Market
92 pages | Janvier 2005 |
IntroductionThe global cancer market is predicted to grow at a CAGR exceeding 10%.
However, a number of global and country-specific factors will support or threaten this trend including epidemiolog |
12 160,00 €
|
| |
| |
Prevention of Coronary Heart Disease - Promoting Healthy Lifestyles
39 pages | Juillet 2005 |
IntroductionCoronary heart disease is the most common cause of death in Europe and the US, at a rate of one in five.
However, the majority of coronary events can be prevented by education about ris |
1 520,00 €
|
| |
| |
Future Health Trends in Food and Drinks: Growth opportunities in daily dosing, GI, heart health, right fats and phood
196 pages | Août 2005 |
The GI diet is being driven due to rising obesity, rising diabetes and because the diet can be essentially seen as a sophistication of the Atkins diet; manufacturers are driving the trend by tailoring |
1 623,50 €
|
| |
| |
Hemoglobin A1c Monitoring
245 pages | Octobre 2005 |
This report analyzes the worldwide markets for Hemoglobin A1c Monitoring in Millions of US$.
The specific product segments analyzed are HbA1c Laboratory Testing, and HbA1c Point of Care Testing & S |
3 091,00 €
|
| |
| |
PharmaVitae 2005: Novo Nordisk Global and US Analysis
148 pages | Octobre 2005 |
IntroductionThis analysis examines the current position and future outlook for Novo Nordisk in the ethical pharmaceutical sector.
The profile encompasses global company strategy, portfolio and pipe |
4 845,00 €
|
| |
| |
Stakeholder Insight: Dyslipidemia - Statins Dominate Treatment Pathway - For Now
204 pages | Octobre 2005 |
IntroductionDatamonitor estimates that there are 267m people in the seven major markets with total cholesterol >200mg/dL which is set to rise to 287m in 2015.
Despite this vast patient potential, l |
12 920,00 €
|
| |
| |
Cardiac Rhythm Management Devices World Markets
188 pages | Mai 2004 |
This report focuses on the U.S.
market and worldwide sales and market trends for pacemakers, defibrillators, leads, and other related cardiac rhythm devices.
The cardiac rhythm management market |
800,00 €
|
| |
| |
PROactive Results - The Diabetes Trial That Could Have Been
40 pages | Novembre 2005 |
IntroductionThe socio-economic consequences of diabetes and its complications make it a major public health issue.
Patients with diabetes have a 25% reduction in life expectancy compared with the g |
3 230,00 €
|
| |
| |
The Blockbuster Drugs Outlook: Optimum management strategies throughout the product lifecycle
258 pages | Mai 2001 |
Cost containment pressures have increased the need for pharmaceutical companies to launch innovative, new drugs with sales potentials in excess of $1bn.
In addition to this, companies must ensu |
955,00 €
|
| |
| |
Innovation in Functional Food and Drinks: Growth opportunities from new nutraceutical ingredients
178 pages | Novembre 2005 |
Cardiovascular epidemiology data shows there will be increasing opportunities for cholesterol lowering products and functional health products with heart health benefits, particularly in the UK, Germa |
1 623,50 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Laboratory Assessment of Diabetic Vascular Disease |
|
|
This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specific data points. The Database Table is NOT a report or a comprehensive analysis.
|
|
|
PPLSEN
|
|
|
|
|
